This presentation is Proprietary and no portion of it may be utilized without the permission of Bio- Investigations Ltd. ENHANCING THE VALUATION OF EXTERNALLY-DERIVED.

Slides:



Advertisements
Similar presentations
U.S. Civilian Research & Development Foundation Peace and prosperity through science collaboration 1 Cathleen Campbell U.S. Civilian Research & Development.
Advertisements

Business Development Licensing Strategic Marketing HFA-Consulting.com Pharmaceutical Business Development & Licensing Consultancy HFA provides specialist.
SAFETY NET NETWORK LEADERSHIP AND ADVISORY GROUP MEETING Wednesday, June 19, 2013.
Private Sector Perspectives on Federal Financial Systems Modernization and Shared Services.
LICENSING “One Way of Putting Your I.P. to Work for Your Organization” Inventing and Patenting Seminar May 16, 2001.
Principal Patent Analyst
Charles D. Smith, Ph.D. April, 2012.
CCTC Background Process coordinated by NASDCTEc 42 states, DC, and one territory involved in development Modeled the process and outcomes of Common Core.
MARKET RESEARCH ■ PRODUCT DESIGN ■ PRODUCT POSITIONING Development and positioning strategies for investment products.
Green Manufacturing Industrial Consortium Western Michigan University David Meade, PhD., Associate Director.
Research Issues & Projects On behalf of the Research Team 17 March 2005.
Lecture 3 Strategic Planning for IT Projects (Chapter 7)
© American Bar Association Effective Strategic Planning Henry F. White, Jr. Executive Director & Chief Operating Officer American Bar Association 10 th.
Centre National pour la Recherche Scientifique et Technique CNRST TEER Unité des Technologies et Économie des Énergies Renouvelables Existing institutions.
bv02 Inc.® 2006 Sponsorship Marketing How to Measure the Effectiveness of your Sponsorship Marketing Program.
Fox Valley Technical College Fab Lab Profile Fox Valley Technical College Fab Lab Profile FOURTH INTERNATIONAL FAB LAB FORUM & SYMPOSIUM AUGUST 2007 FOURTH.
Online Technology Marketplaces and Technology Brokers – Insights on how they can work for you Denise Lalanne June 18, 2004.
Tech Launch Arizona Tech Transfer Arizona Rakhi Gibbons, Asst. Director for Biomedical and Life Sciences Licensing.
Presented by Vladimir Yossifov Consultant, IP Services “IP Universities” Istanbul, May 16 to 18, 2012 Albert Long Hall, BOGAZICI UNIVERSITY.
All information contained within this document is proprietary to Risk Limited Corporation. prepared by Commercial Real Estate Hedging & Risk Management.
1 Enterprise Risk Management (ERM) Program PNM Resources, Inc. March 29, 2007 Presentation to American Public Power Association March 2007 Austin, Texas.
UNM and Health System Internal Audit Departments Internal Audit Department Orientation Manu Patel, Internal Audit Director Purvi Mody, Executive Director,
NCI Review of the Clinical Trials Process 6 th Annual National Forum on Biomedical Imaging in Oncology James H. Doroshow M.D. April 7, 2005 Bethesda, Maryland.
PROMOTING TECHNOLOGY TO INDUSTRY Technology transfer objectives: enhance commercial value of invention promote technology to partner / investor identify.
Tech-Sector Tech Marketing and Corporate Structure Advisory Services advisory group inc.
A project implemented by the HTSPE consortium This project is funded by the European Union SECURITY AND CITIZENSHIP.
София European Experts for Development. София COMPANY PROFILE „Kavangard” Ltd. is a consultancy company, working in the sphere of the regional development,
The Financial Accounting Foundation The Financial Accounting Foundation Advancing Financial Reporting.
Deeper IBM Global Business Services © Copyright IBM Corporation 2008 Investor’s Cafe Investor-driven marketing of your location October 8 th 2008.
Strategies for Innovation Sourcing 30 August 2007 Paul McGowan Center for Innovative Technology Herndon, VA / Strategies.
0 Main Problems of Access to Market Information in Russia O.B.Saluleva, Head of the Technology Transfer Office, Innovation Business Center, Yekaterinburg.
Managing Medical R&D Defining and Realizing Clinical and Commercial Value David J. Wierz Senior Director Commercial Investment & Pricing Strategy Wyeth-Ayerst.
SPI USA, Inc. 4,5/4,5 CM Introducing a Way of Thinking About the Process of Partnering Asking the right questions By Elia Cossis Your Partner for Innovation.
Beyond and Decisions: From Problem Formulation to Dose- Response.
1 Maryland Life Sciences Advisory Board William E. Kirwan, USM Chancellor Wednesday September 24, 2008.
Learning Objective Chapter 3 The Marketing Research Industry and Research Ethics CHAPTER three The Marketing Research Industry and Research Ethics Copyright.
EFP7 STRATEGY IT tools supporting beneficiaries and other external users 23/06/2010.
China Healthcare Consulting Inc. Creating Value for Our Clients Boston Healthcare Associates, Inc. 75 Federal Street, 9 th Floor.
Graduate studies - Master of Pharmacy (MPharm) 1 st and 2 nd cycle integrated, 5 yrs, 10 semesters, 300 ECTS-credits 1 Integrated master's degrees qualifications.
FINANCIAL experts INDUSTRY Some of our clients. Financial translation has become a necessary service, not just within the financial industry but also.
THE IMPORTANCE OF IPR ACROSS THE LIFECYCLE OF INNOVATION Bob Stembridge Principal Patent Analyst, IP & Science.
Financing Innovation March 25, 2004 Knowledge Economy Forum III Budapest, Hungary NATIONAL INNOVATION FUND KAZAKHSTAN.
A project implemented by the HTSPE consortium This project is funded by the European Union SECURITY AND CITIZENSHIP RIGHT AND CITIZENSHIP
Marv Adams Chief Information Officer November 29, 2001.
24 October,2013 Technology Transfer Office “Information and Communication Technologies for Energy Efficiency” TTO “ICTEE” AComIn – Starosel, Bulgaria.
1 Gary Williams – Director Jeni Clark – Associate Director New Product Development May 16,2012.
Atlantic Innovation Fund Round VIII February 5, 2008.
Intellectual Property Right Bernard Denis, DG-KTT.
NATIONAL CONFERENCE Intellectual Property Policies for Universities and Innovation dr. sc. Vlatka Petrović Head, Technology Transfer Office Acting Head,
Policy on the Management of Intellectual Property in Technology Transfer Activities at CERN CERN/FC/5434/RA Technology Transfer Network Meeting – 10 th.
Background regarding a Proof-of-Concept program for developmental research on OIST IP Expanded comments are included in Notes at the bottom of the slides.
Partnering With Industry for Clinical Research Luke Lin, MD, and Ralf Schnall.
Knowledge Transfer Accelerating Innovation. slide 1 The Knowledge Transfer Group at the HR Induction Program (session II) 6 th September 2011 Enrico Chesta.
MarketsandMarkets Presents Dallas, TX Market Research Company and Consulting Firm
128/02/2011 Confidential Who is Alcimed ? ALCIMED is a European consulting company specialized in Life Sciences/Healthcare and Chemicals, founded in 1993.
Review of Research-Related Agreements Between Academic Institutions and Other Entities. Manoja Ratnayake Lecamwasam, PhD Intellectual Property and Innovation.
TECHNOPOLIS OYJ Access to Customers, Capital and Partners Development Services.
Canadian SNOMED CT Strategy October 2012 Draft. Content 1 Background Approach Current State Future State Considerations Action Plan.
The Basque Foundation for Health and Innovation Research Demotek Demonstration Unit of Innovative Technologies in Health An opportunity for.
Knowledge Transfer Accelerating Innovation. slide 1 The Knowledge Transfer Group at the HR Induction Program (session II) 9 th June 2011 Giovanni Anelli.
Zenithinternational specialist consultants to the food and drink industries worldwide STRATEGY & MANAGEMENT  MERGERS & ACQUISITIONS  COMMERCIAL & MARKET.
Innovation Manager SPECIFIC DUTIES AND RESPONSIBILITIES Manage new product projects from concept through commercialization. Partner with Brand Teams to.
OTC FELLOWS PROGRAM INFORMATION SESSION Fall 2016.
Global Electronic Data Capture (EDC) Systems Market Primary Research, Risk Analysis, Product Research, Trends and Forecast by 2022 Phone No.: +1 (214)
Director Department for Transition and Developed Countries
Transfer of Medical Devices Manufacturing Technology
MAZARS’ CONSULTING PRACTICE
Expert Panel Medical Diagnostic Imaging Specialist Consultants
Empyrean Consulting, Inc.
Industry Blend Service Company B2B B2C Product Company
Presentation transcript:

This presentation is Proprietary and no portion of it may be utilized without the permission of Bio- Investigations Ltd. ENHANCING THE VALUATION OF EXTERNALLY-DERIVED TECHNOLOGY: A SYSTEMS APPROACH Bio-Investigations Ltd. Madison, CT December 2013

“ Externally-Derived Technology ” ( EDT) encompasses technology (including service models) identified, patented, and/or developed outside of a major multinational corporation. It ’ s origin may include universities, service providers, biotechnology companies, and/or entities established by prolific Inventors.

Sources of EDT may include: University of Connecticut Health Center, Farmington, CT – Center for Science & Technology Commercialization University of Connecticut Health Center, Farmington, CT – Center for Science & Technology Commercialization Inventions of Drs. XX, YY, XZ Inventions of Drs. XX, YY, XZ University of Calgary ’ s UTI University of Calgary ’ s UTI Fox Chase Cancer Center Fox Chase Cancer Center University of Nebraska Medical Center University of Nebraska Medical Center American Imaging, Inc. American Imaging, Inc.

What is the Problem? Major multinationals often have fully committed their internal R&D resources and are unable to react to major technologic and market opportunities that involve “ Technology ” and/or business models discovered externally. Major multinationals often have fully committed their internal R&D resources and are unable to react to major technologic and market opportunities that involve “ Technology ” and/or business models discovered externally. The “ not-invented here syndrome ” clouds objectivity in evaluating technology. The “ not-invented here syndrome ” clouds objectivity in evaluating technology.

What is the Opportunity? A major objective of Bio-Investigations Ltd. is the identification of, and negotiation for, major Externally Derived Technology, either within the North American continent or on a global basis. A major objective of Bio-Investigations Ltd. is the identification of, and negotiation for, major Externally Derived Technology, either within the North American continent or on a global basis. The existing in-licensing model, and present University connections to bring in EDT by the major multinationals, are not efficient. The existing in-licensing model, and present University connections to bring in EDT by the major multinationals, are not efficient.

What Options Exist to Aid In Advancing Externally-Derived Technology? Consortium Approach, Drawing Proactively on Qualified Universities; Consortium Approach, Drawing Proactively on Qualified Universities; Contract Research Organizations; Contract Research Organizations; Clinical Research Organizations; Clinical Research Organizations; Specialized Service Providers (i.e., AI); Specialized Service Providers (i.e., AI); All of the above, Managed by a TCO All of the above, Managed by a TCO

Battelle Memorial Institute ( A Contract Research Organization: serves industry and government in developing new technologies and products; serves industry and government in developing new technologies and products; advances each year thousands of technology projects at their various business operations; advances each year thousands of technology projects at their various business operations; is an organization that focuses on contract research and the commercialization of innovative technology. is an organization that focuses on contract research and the commercialization of innovative technology.

Clinical Research Organizations are Interacting with Externally-Derived Technology in More Ways Than Most Realize, And Participate in the Valuation Cycle Examples Include: Examples Include: – PAREXEL International Corporation – Covance Inc. – Client Associated Businesses, Inc. – Quintiles Transnational Corporation

ADVANCING TECHNOLOGY EXTERNALLY ALLOWS FOR AN INCREASE IN IT ’ S VALUATION

Externally-Derived Technology Must Pass A Pre-Defined Scientific Filter to be Advanced Into The Full Assessment Cycle

Technical Reviewers Are Specialists In their Respective Areas, And Are Charged to Generate Independent Assessments A Consensus on Scientific and/or Business Merit Allows for Advancement Into: A Consensus on Scientific and/or Business Merit Allows for Advancement Into: –Intellectual Property Review Freedom To Operate Analysis Freedom To Operate Analysis –Market Assessment –Medical Analysis

What is the Solution? The identification of key “ Technology ” by Bio-Investigations Ltd. may be successfully leveraged by major multinationals through the utilization of external organizations. The identification of key “ Technology ” by Bio-Investigations Ltd. may be successfully leveraged by major multinationals through the utilization of external organizations. Service providers have the opportunity to participate in increased technology valuation. Service providers have the opportunity to participate in increased technology valuation.

The following slides are subsequent to XXXX-related activities, conducted on: Executive Strategy Session, XX, 10 May 20XX; Executive Strategy Session, XX, 10 May 20XX; Database Strategy Session, XX, 26 May 20XX; Database Strategy Session, XX, 26 May 20XX; R&D N.A. Consultation, XX, 26 May 20XX; R&D N.A. Consultation, XX, 26 May 20XX; Bio-Investigations Ltd. Biomarker Filtering Audit Session, CT, May 20XX Bio-Investigations Ltd. Biomarker Filtering Audit Session, CT, May 20XX

The Technology Review Committee will be Comprised of 6 Individuals, all Initially Providing Independent Assessments 2 Members – XXX – XXX 2 Members – XXX – XXX 1 Member – External Expert – U.S. 1 Member – External Expert – U.S. 1 Member – External Expert - Canada 1 Member – External Expert - Canada

XXX Biomarker Consortium – A Proposal for Implementation - 1 June 20XX Externally Derived Technology Externally Derived Technology Technology Review Committee GO Decision GO Decision Working Discussion Targeted Toward Clear Decision Working Discussion Targeted Toward Clear Decision GO Decision GO Decision NO-GO Decision NO-GO Decision 0, 1, or 2 Positives NO-GO Decision NO-GO Decision 0, 1, 2, or 3 Positives 4, 5, or 6 Positives 5 or 6 Positives 3 or 4 Positives Commercialization Process Commercialization Process Int. Prop. Analysis Int. Prop. Analysis Market Assessment Market Assessment Medical Analysis Medical Analysis